Anzeige
The technology regards the use of an oral elastase inhibitor for the prophylaxis and therapy of pancreatitis.The innovative aspect is particularly the combination of inhibiting the neutrophil and pancreatic elastase by means of one inhibitor.
Further Information: PDF
PVA Mecklenburg-Vorpommern AG
Phone: +49 (0)381/49 74 74 0
Contact
Antonio Martinez
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
info@technologieallianz.de | Source: TechnologieAllianz e.V.
Further information: www.technologieallianz.de/angebote.php?sort=sag&id=0522&lang=en
www.technologieallianz.de
More articles from
Technology Offerings:
Environment-friendly and Cost-efficient Production of Functional Metal Oxide Films
07.01.2009 | TechnologieAllianz e.V.
Improved Detector Head for Spektrometric Devices
07.01.2009 | TechnologieAllianz e.V.
California study shows shade trees reduce summertime electricity use
07.01.2009 | Studies and Analyses
Jupiter-like Planets Could Form Around Twin Suns
07.01.2009 | Physics and Astronomy
Tackling climate change with new permits to pollute
07.01.2009 | Ecology, The Environment and Conservation
Annual Congress European Association of Urology: highlights in Stockholm
18.12.2008 | Event News
PRACE hosts First Scientific Conference
16.12.2008 | Event News
USM Conference Explores Issues And Challenges In The Global Construction Sector
10.12.2008 | Event News